Author name: Gertrud U. Rey

Gertrud Rey (who also goes by Trudy Rey) is a trained virologist who resides in Atlanta, Georgia. She has a PhD in molecular genetics and biochemistry from Georgia State University, where her studies involved the analysis of various aspects of the genetics of West Nile virus and simian hemorrhagic fever virus. After finishing the PhD program in 2007, she accepted a post-doctoral fellowship at the Centers for Disease Control and Prevention, where she continued to study virology in the context of respiratory syncytial virus, with a more pronounced focus on immunology. During that time, she was also a lecturer at Georgia State University, where she designed an undergraduate biology course and supervised teaching assistants at the university’s biology laboratory. In 2012, she decided to retire from bench science and lecturing to pursue a career in patent law. She is now registered as a patent agent at the U.S. Patent and Trademark Office, and works for a major law firm. Her day to day responsibilities include preparing and prosecuting U.S. and international patent applications in the field of molecular and cell biology, virology, biochemistry, genetic engineering, tissue engineering, transgenic biology, stem cell research, immunology, drug delivery, phage therapeutics, and medical devices. However, Trudy still spends much of her free time communicating science, both for virology blog, and for her very own YouTube channel, where she hosts a show about viruses called “Catch This.” You can also find her on X, under the handle “Dr. T.” Trudy was also a guest on TWiV 179 and 424.

There Is Something to Be Gained From Gain of Function Experiments

2 Comments / Basic virology, Gertrud Rey / By

by Gertrud U. Rey In recent years, the phrase “gain of function” and its abbreviation “GoF” have attained a sinister connotation that is coupled with a general mistrust toward scientists who engage in this type of experimentation. This public perception is grounded in a basic misunderstanding of what constitutes GoF and a lack of appreciation …

There Is Something to Be Gained From Gain of Function Experiments Read More »

An mRNA Vaccine to Treat Cancer

1 Comment / Basic virology, Gertrud Rey / By

by Gertrud U. Rey There are several highly effective vaccines that block infection by human papillomaviruses (HPVs) and thereby prevent the cervical, anogenital, and head and neck cancers caused by these viruses. However, none of these vaccines are effective for the treatment of established HPV-induced tumors. The success of the COVID-19 messenger RNA (mRNA) vaccines …

An mRNA Vaccine to Treat Cancer Read More »

H5N1 – It’s All About the Transmission

3 Comments / Basic virology, Gertrud Rey / By

by Gertrud U. Rey Recent news headlines have been highlighting the global spread of H5N1, the strain of influenza virus that is typically associated with “bird flu.” This outbreak is the largest in recorded history, involving at least 50 million dead birds and countless non-human mammals, including sea lions, otters, mink, foxes, cats, dogs, and …

H5N1 – It’s All About the Transmission Read More »

“Paxlovid Rebound” Is Just COVID Rebound

3 Comments / Basic virology, Gertrud Rey / By

by Gertrud U. Rey The antiviral drug Paxlovid is highly effective at inhibiting SARS-CoV-2 replication and reducing symptoms associated with COVID-19. Nevertheless, there have recently been numerous reports of recurrence of positive tests and symptoms after completing treatment with Paxlovid, leading some to infer that the drug triggers the recurrence. Is this inference actually correct, …

“Paxlovid Rebound” Is Just COVID Rebound Read More »

Antibodies Against SARS-CoV-2 Nucleocapsid Protein May Not Be Reliable Markers for Infection in Vaccinated People

1 Comment / Basic virology, Gertrud Rey / By

by Gertrud U. Rey You are fully vaccinated against SARS-CoV-2 and have presumably never been infected with the virus. But how can you know for sure? One way to find out is by testing your blood for the presence of antibodies against the viral nucleocapsid protein, which can only be encountered during natural infection. This …

Antibodies Against SARS-CoV-2 Nucleocapsid Protein May Not Be Reliable Markers for Infection in Vaccinated People Read More »

Scroll to Top